Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Faster EU Drug Assessment Pathway Takes Shape: Convergence With US Breakthrough Designation On the Cards

This article was originally published in SRA

Executive Summary

EU drug regulators are pressing on with plans to develop an early-stage innovative medicines designation-type scheme to support the development of and speed access to drugs that address major public health needs.

Advertisement
Advertisement
UsernamePublicRestriction

Register